<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03606083</url>
  </required_header>
  <id_info>
    <org_study_id>PLIANTII</org_study_id>
    <nct_id>NCT03606083</nct_id>
  </id_info>
  <brief_title>Registry in Patients With Aorto-iliac or Iliac Aneurysms</brief_title>
  <acronym>PLIANTII</acronym>
  <official_title>Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni- or Bilateral Aorto-iliac or Iliac Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>JOTEC GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>JOTEC GmbH</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PLIANT II registry is undertaken to examine the real-world outcome after treatment of
      consecutive patients with uni- or bilateral aorto-iliac or iliac aneurysms using the E-liac
      Stent Graft System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, patients will be observed who receive one or two E-liac Stent Graft(s) for
      aorto-iliac or iliac aneurysms. The E-liac Stent Graft(s) will be implanted at the discretion
      of the treating physician. Participating physicians will be asked to provide their
      observations collected during routine care for patients he/she had decided to treat with the
      E-liac Stent Graft System. Informed consent of the patients to allow the use of their
      clinical records for the purpose of this observational study will be obtained before
      intervention and before data are being collected.

      The period of data collection will be 60 months starting from the intervention for each
      patient. 100% verification of patient informed consent and essential study documents will be
      performed at each study site. 60% of patient´s source documentation will be randomly
      monitored.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2029</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from endoleak type I or III and patency of EIA and IIA on E-liac implantation side(s)</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of patients that reach the primary endpoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>24 hours</time_frame>
    <description>Rate of all cause mortality in peri-operative periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm size</measure>
    <time_frame>12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with decreasing, stable, increasing aneurysm size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary patency of EIA / IIA</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with primary patency of EIA / IIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary patency of EIA / IIA</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with secondary patency of EIA / IIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent graft dislodgement</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with stent graft dislodgement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type I</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with infrarenal type Ia endoleak</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type Ia in the CIA (isolated iliac aneurysm treatment)</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with infrarenal type Ia endoleak</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type Ib in the CIA</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with endoleak type Ib in the CIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type Ib in the EIA</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with endoleak type Ib in the EIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type Ib in the IIA</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with endoleak type Ib in the IIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type II</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with endoleak type II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak type III</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with endoleak type III</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent fracture</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with stent fracture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reintervention</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate patients with reintervention after E-liac Stent Graft implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Claudication</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with increasing, stable, decreasing claudication (walking distance without pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>prior to discharge / 30 days, 12, 24, 36, 60 months</time_frame>
    <description>Rate of patients with adverse events (product-related, procedure-related, aneurysm-related)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Vascular Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular repair</intervention_name>
    <description>Endovascular repair of aorto-iliac or iliac aneurysms using an iliac branch device (IBD)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female patients with uni- or bilateral aorto-iliac or iliac aneurysm, treated with
        the E-liac Stent Graft System.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 85 years

          -  Patient must have an aorto-iliac or iliac aneurysm

          -  Patient must have a unilateral or bilateral iliac aneurysm

          -  Patient´s anatomy must be suitable for stent graft placement on preoperative angio CT
             scan

          -  Patient must be available for the appropriate follow-up times for the duration of the
             study

          -  Patient has been informed of the nature of the study, agrees to its provisions and has
             signed the informed consent form prior to intervention

        Exclusion Criteria:

          -  Female of child bearing potential

          -  Patients with ruptured iliac aneurysms

          -  Patients with juxtarenal, pararenal or suprarenal aneurysms

          -  Patients pretreated with Nellix (Endologix) or Altura (Lombard Medical)

          -  Patient is currently participating in an investigational drug or device study that has
             not completed the primary endpoint or that clinically interferes with the current
             study endpoints

          -  Patient with malignancy needing chemotherapy or radiation

          -  Patients with life expectancy of less than 3 years

          -  Patient minor or under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Brunkwall, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cologne University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heike Fischer, Dr.</last_name>
    <phone>+49 151 153 97 110</phone>
    <email>fischer.heike@cryolife.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Brunkwall, Prof.</last_name>
      <phone>+4922147832498</phone>
      <email>gefaesszentrum@uk-koeln.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Anton S, Wiedner M, Stahlberg E, Jacob F, Barkhausen J, Goltz JP. Initial Experience with the E-liac(®) Iliac Branch Device for the Endovascular Aortic Repair of Aorto-iliac Aneurysm. Cardiovasc Intervent Radiol. 2018 May;41(5):683-691. doi: 10.1007/s00270-017-1868-x. Epub 2018 Jan 3.</citation>
    <PMID>29299625</PMID>
  </reference>
  <reference>
    <citation>Mylonas SN, Rümenapf G, Schelzig H, Heckenkamp J, Youssef M, Schäfer JP, Ahmad W, Brunkwall JS; E-liac Collaborative Group. A multicenter 12-month experience with a new iliac side-branched device for revascularization of hypogastric arteries. J Vasc Surg. 2016 Dec;64(6):1652-1659.e1. doi: 10.1016/j.jvs.2016.04.065. Epub 2016 Aug 1.</citation>
    <PMID>27492764</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 29, 2018</study_first_submitted>
  <study_first_submitted_qc>July 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2018</study_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aorto-iliac</keyword>
  <keyword>iliac</keyword>
  <keyword>aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Iliac Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

